Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

2004 ◽  
Vol 21 (7) ◽  
pp. 730-737 ◽  
Author(s):  
M. E. Piché ◽  
J. P. Després ◽  
A. Pascot ◽  
A. Nadeau ◽  
A. Tremblay ◽  
...  
Author(s):  
Kate E. Cohen ◽  
Boran Katunaric ◽  
Gopika SenthilKumar ◽  
Jennifer J. McIntosh ◽  
Julie K. Freed

Cardiovascular disease risk increases with age regardless of sex. Some of this risk is attributable to changes in natural hormones throughout the lifespan. The quintessential example of this being the dramatic increase in cardiovascular disease following the transition to menopause. Plasma levels of adiponectin, a "cardioprotective" adipokine released primarily by adipose tissue and regulated by hormones, also fluctuates throughout one's life. Plasma adiponectin levels increase with age in both men and women, with higher levels in both pre- and post- menopausal women compared to men. Younger cohorts seem to confer cardioprotective benefits from increased adiponectin levels yet elevated levels in the elderly and those with existing heart disease are associated with poor cardiovascular outcomes. Here, we review the most recent data regarding adiponectin signaling in the vasculature, highlight the differences observed between the sexes, and shed light on the apparent paradox regarding increased cardiovascular disease risk despite rising plasma adiponectin levels over time.


2009 ◽  
Vol 26 (7) ◽  
pp. 533-538 ◽  
Author(s):  
Faustino R. Pérez-López ◽  
José L. Cuadros-López ◽  
Ana M. Fernández-Alonso ◽  
Angela M. Cuadros-Celorrio ◽  
Rosa M. Sabatel-López ◽  
...  

2009 ◽  
Vol 34 (2) ◽  
pp. 136-142 ◽  
Author(s):  
Jian Liu ◽  
Divya Joshi ◽  
Christopher T. Sempos

To evaluate how non-high-density-lipoprotein (non-HDL) is associated with impaired fasting glucose (IFG) and clustered metabolic risk (MR) factors among adolescents, we pooled 2764 adolescents, aged 12–19 years, from the National Health and Nutrition Examination Survey from 3 time periods (1999–2000, 2001–2002, and 2003–2004) who were free of diabetes and had fasted overnight for this analysis. IFG was defined as 100 ≤ glucose ≤ 125 mg·dL–1. Age- and sex-specific cut-offs were used for 4 MR factors: higher levels of triglycerides, waist circumference, blood pressure, and lower levels of HDL. Clustered MR was defined as having any 2 of the 4 factors. Overall, approximately 11% of adolescents had IFG. The mean level of non-HDL cholesterol was much higher in those with IFG than in those without IFG, with adjustment for certain confounding variables (121.4 vs. 110.1 mg·dL–1; p < 0.05). This difference could still be observed in adolescents with one or more clustered MR factors. However, there were no statistical differences in low-density-lipoprotein (LDL) level. Compared with those who were without IFG and not at high levels of non-HDL — after adjustment for age, sex, race, current smoking, and body mass index — the odds of having clustered MR factors were 1.08 (95% CI, 0.65–1.82) for those with IFG and low non-HDL cholesterol, 3.55 (2.29–5.48) for those without IFG but with high non-HDL cholesterol, and 10.10 (3.67–27.80) for those with both IFG and high non-HDL cholesterol. Moreover, those with IFG and at increased risk of obesity were more likely to have higher levels of non-HDL cholesterol (odds ratio (95% CI): 4.41 (2.28–8.50)), compared with those without IFG and not at increased risk of obesity. In summary, prediabetic adolescents with IFG and high levels of non-HDL cholesterol are more likely to have clustered MR factors. Thus, the levels of non-HDL cholesterol may be an important indicator in monitoring cardiovascular disease risk among adolescents with IFG.


2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Sek Ying Chair ◽  
Qun Wang ◽  
Ho Yu Cheng ◽  
Sally Wai-Sze Lo ◽  
Xiao Mei Li ◽  
...  

Circulation ◽  
2012 ◽  
Vol 125 (suppl_10) ◽  
Author(s):  
Eric A Whitsel ◽  
Quynh C Nguyen ◽  
Chirayath M Suchindran ◽  
Joyce W Tabor ◽  
Carmen C Cuthbertson ◽  
...  

Little is known about the biomarker-based prevalence of diabetes among U.S. adults aged 24-32 years, an age group historically characterized by low cardiovascular disease risk. We addressed the paucity of information within this age group among 15,701 participants at Wave IV of the National Longitudinal Study of Adolescent Health (Add Health, 2008), a study including nationally representative oversamples of racial / ethnic groups underrepresented by the National Health and Nutrition Examination Survey (NHANES). Capillary whole blood was collected via finger prick onto Whatman 903® Protein Saver cards by trained and certified field interviewers, desiccated, then shipped to central laboratories for assay and archival. Sensitivity of the glucose assay was 22 mg/dl. Assayed values in the lowest half percentile of the distribution were re-assayed. Re-assayed and original values were averaged. The within- and between-assay coefficients of variation (CVs) were 4.4% and 4.8%. For HbA 1c , the corresponding sensitivity, within- and between-assay CVs were 3%, 2.2%, and 2.4%. In paired serum and blood spots, glucose concentrations (mg/dl) were strongly associated (n = 83; Pearson r = 0.97). Associations were equally strong for HbA 1c (%) in paired whole blood and blood spots (n = 80; Pearson r = 0.99). In a race/ethnicity- and sex-stratified random sample of 100 Add Health participants among whom capillary whole blood was collected twice, one to two weeks apart, reliability of random (fasting ≥ 8 hr or non-fasting) glucose and HbA 1c was estimated as an intra-class correlation coefficient and 95% confidence interval, ICC (95% CI): 0.39 (0.21, 0.58) and 0.97 (0.96-0.98). Add Health participants were more likely than similarly aged NHANES (2007-2008) participants to be native-born, insured, college educated, and overweight or obese. After weighting for unequal sampling probabilities and clustering, mean (standard deviation) HbA 1c and fasting glucose were higher in Add Health than NHANES: 5.6% (0.8%) and 107 (35) mg/dl vs. 5.2% (0.5%) and 97 (14) mg/dl. The weighted prevalence (95% CI) of HbA 1c ≥ 6.5% and fasting glucose ≥ 126 mg/dl also were higher in Add Health than NHANES: 3.6% (2.9-4.3) and 10.3% (8.7%-12.2%) vs. 1.7% (0.9%-3.2%) and 2.1% (0.8%-5.5%). Corresponding odds ratios (95% CIs) were: 2.1 (1.1-3.9) and 5.2 (2.1-13.3). Adjustment for sociodemographic, clinical and behavioral risk factors attenuated the associations: 1.5 (0.8-3.1) and 4.2 (1.7-10.4). However, the addition of self-reported history of diabetes and use of anti-diabetics had relatively little effect on them. Carefully standardized, in-home collection of whole blood spots can yield valid and reliable estimates of glucose and HbA 1c . Their interpretation in context of the prevalent obesity and hypertension at Add Health Wave IV reinforces suggestions that young, U.S. adults face a historically high risk of cardiovascular disease.


Sign in / Sign up

Export Citation Format

Share Document